Photobiomodulation (BL)

Photobiomodulation

Photobiomodulation is the mechanism by which non-ionizing optical radiation in the visible and near-infrared spectral range is absorbed by endogenous chromophores to elicit photo-physical and photo-chemical events at various biological scales. Photobiomodulation Therapy (PBMT) is a form of light therapy based on the principles of photobiomodulation. It involves the use of light sources including lasers, LEDs, and broadband light, in the visible and infrared spectrum to cause physiological changes and therapeutic benefits. PBMT has the potential to revolutionize modern healthcare and is being used by veterinarians, dentists and physical therapists for a number of applications including tissue regeneration, pain relief and regulation of inflammation. New areas of research include as age-related macular degeneration, spinal cord injury, and traumas and pathologies of the brain. The focus of the OSA Photobiomodulation Technical Group will be to develop guidelines to help ensure safety, efficacy and scientific accuracy in photobiomodulation research and technology development.
CLEO: 2017 (14- 19 May 2017 in San Jose, California)
 
CLEO is a premier international forum for scientific and technical optics, sponsored by APS Physics, IEEE Photonics, and The Optical Society. A specialized session focused on “Photobiomodulation Therapeutics” is organized in the CLEO: 2017 A&T Biomedical Applications Track, which will be chaired by Dr. Ilko Ilev. The session, which will take place on Tuesday, 16 May, from 13:30 – 15:30 in Executive Ballroom 210A, will include invited and contributed papers presented by distinguished experts worldwide on the recent developments in the areas of photobiomodulation therapeutic technologies and medical devices.
 
Professor Juanita Anders will be giving a key invited talk entitled “Emerging Photobiomodulation Therapeutics”. Dr. Ilev will also present a talk focused on PBMT mechanisms entitled “Label-free sensing of intrinsic biomarkers related to medical device performance employing a noninvasive fingerprint infrared spectroscopy method”. If you are at CLEO, please introduce yourself to Dr. Anders and Dr. Ilev, the chair and vice chair of the Photobiomodulation Technical Group, after the “Photobiomodulation Therapeutics” Session.

NameAffiliationTitle
Juanita Anders USUHSChair
Ilko K. Ilev U.S. Food and Drug AdministrationVice Chair
Ronald Riegel American Institute of Medical Laser ApplEvents Officer
Gail Siminovsky, CAE Academy of Laser DentistryEvents Officer
James Carroll THOR Photobiomodulation LtdSocial Media Officer
Wendy Frydrych LiteCure, LLCSocial Media Officer
Praveen Arany University at BuffaloWebinar Officer
Michael R. Hamblin Massachusetts General HospitalWebinar Officer

18 September 2017

Michel Hotel
Suhl, Germany


Become a members of our newest technical group today! OSA Members can join the Photobiomodulation Technical Group by updating their profile in My Account.

Join the Photobiomodulation Techical Group >>
                         
 
In 2015, leaders of this technical group hosted an OSA Incubator Meeting focused on the discussion and dissemination of scientifically sound research in the field of Photobiomodulation. You can read more about this meeting in the following blog posts:
Ron Waynant, an OSA Fellow, played an instrumental role in establishing the credibility of Photobiomodulation in the academic community and funding agencies in the United States. His sad passing in 2016 is a great loss to the Photobiomodulation community.